Keytruda (pembrolizumab) authorized by HAS to treat triple negative breast cancer
© ShutterstockEvery year, around 9000 French people are diagnosed with triple negative breast cancer (TNBC): fortunately rare, this cancer (which ...
Read moreTag: Keytruda
Merck’s flagship product, Keytruda, effective against cancer
April 18, 2018. Merck announced on Monday April 16 that the study evaluating Keytruda as a monotherapy in the treatment ...
Read more